{"id":2378,"date":"2020-10-05T08:40:32","date_gmt":"2020-10-05T06:40:32","guid":{"rendered":"https:\/\/cendoc.h12o.es\/blog\/?p=2378"},"modified":"2020-10-05T08:40:32","modified_gmt":"2020-10-05T06:40:32","slug":"cancer-de-prostata-covid-19-y-h12o","status":"publish","type":"post","link":"https:\/\/cendoc.h12o.es\/blog\/2020\/10\/05\/cancer-de-prostata-covid-19-y-h12o\/","title":{"rendered":"C\u00e1ncer de pr\u00f3stata, COVID-19 y H12O"},"content":{"rendered":"<p data-adtags-visited=\"true\">Luc\u00eda Carril Ajuria, del Servicio de Oncolog\u00eda M\u00e9dica del Hospital 12 de Octubre, es la primera autora del trabajo \u201c<a href=\"https:\/\/www.cancernetwork.com\/view\/challenges-of-treating-a-patient-with-advanced-prostate-cancer-during-the-covid-19-pandemic\">Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic<\/a>\u201d, un caso cl\u00ednico publicado en <em>Oncology<\/em>. Se trata de un <img loading=\"lazy\" decoding=\"async\" class=\" wp-image-3871 alignright\" src=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=182&amp;h=124\" alt=\"logo12\" width=\"182\" height=\"124\" data-attachment-id=\"3871\" data-permalink=\"https:\/\/coronavirusbiblioh12o.wordpress.com\/2020\/05\/06\/7-mas-del-h12o\/logo12\/\" data-orig-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg\" data-orig-size=\"275,183\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"logo12\" data-image-description=\"\" data-medium-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" data-large-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" \/>paciente de 78 a\u00f1os con antecedentes de c\u00e1ncer de pr\u00f3stata, que hab\u00eda sido tratado con abiraterona y docitaxel. Ingres\u00f3 por lesione \u00f3seas y deterioro de la funci\u00f3n renal pasado de un mes de la cuarta sesi\u00f3n de quimioterapia, siendo diagnosticado a los pocos d\u00edas de COVID-19. Tratado con antibi\u00f3ticos, antirretrovirales y heparina, su estado se deterior\u00f3 y se evalu\u00f3 su traslado a domicilio con paliativos, falleciendo a los pocos d\u00edas. Ante este final, los autores se preguntan: \u00bfEl tratamiento que recibi\u00f3 el paciente de 78 a\u00f1os habr\u00eda sido diferente si su \u00faltima progresi\u00f3n no se hubiera producido durante la pandemia? Quiz\u00e1s, si el acceso a la UCI no hubiera estado tan restringido su condici\u00f3n tal vez podr\u00eda haber mejorado con un tratamiento de tercera l\u00ednea con enzalutamida o cabazitaxel. Concluyen que este caso cl\u00ednico es un ejemplo de la combinaci\u00f3n de factores de riesgo predictivos (edad, comorbilidad, tratamiento) que evoluciona a peores resultados con la combinaci\u00f3n de la COVID-19.<\/p>\n<p data-adtags-visited=\"true\"><em>Equipo Biblioteca H12O<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Luc\u00eda Carril Ajuria, del Servicio de Oncolog\u00eda M\u00e9dica del Hospital 12 de Octubre, es la primera autora del trabajo \u201cChallenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic\u201d, un caso cl\u00ednico publicado en Oncology. Se trata de un paciente de 78 a\u00f1os con antecedentes de c\u00e1ncer \u2026<\/p>\n<p class=\"continue-reading-button\"> <a class=\"continue-reading-link\" href=\"https:\/\/cendoc.h12o.es\/blog\/2020\/10\/05\/cancer-de-prostata-covid-19-y-h12o\/\">Continuar leyendo<i class=\"crycon-right-dir\"><\/i><\/a><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[4,64,46],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p3G9TJ-Cm","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2378"}],"collection":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/comments?post=2378"}],"version-history":[{"count":1,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2378\/revisions"}],"predecessor-version":[{"id":2379,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2378\/revisions\/2379"}],"wp:attachment":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/media?parent=2378"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/categories?post=2378"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/tags?post=2378"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}